Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Arcus Biosciences stock have an average target of 25.33, with a low estimate of 13 and a high estimate of 44. The average target predicts an increase of 187.84% from the current stock price of 8.80.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$13	$25.33	$24	$44
Change	+47.73%	+187.84%	+172.73%	+400.00%

Analyst Ratings

The average analyst rating for Arcus Biosciences stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	4	4	4	4	3	3
Buy	6	6	6	6	6	6
Hold	2	2	1	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	11	11	10	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Terence Flynn Morgan Stanley	Morgan Stanley	Buy Maintains $24 → $22	Buy	Maintains	$24 → $22	+150.00%	May 9, 2025
Salveen Richter Goldman Sachs	Goldman Sachs	Hold Maintains $15 → $13	Hold	Maintains	$15 → $13	+47.73%	May 8, 2025
Eva Fortea Verdejo Wells Fargo	Wells Fargo	Buy Maintains $29 → $26	Buy	Maintains	$29 → $26	+195.45%	May 7, 2025
Peter Lawson Barclays	Barclays	Buy Maintains $29 → $14	Buy	Maintains	$29 → $14	+59.09%	Apr 23, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $24	Hold → Strong Buy	Upgrades	$24	+172.73%	Feb 26, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

151.57M

Decreased by -41.25%

from 258.00M

Revenue Next Year

190.63M

Increased by 25.77%

from 151.57M

EPS This Year

-4.27

from -3.14

EPS Next Year

-4.36

from -4.27

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	78.00M	383.00M	112.00M	117.00M	258.00M	151.57M	190.63M	260.14M
Revenue Growth	420.00%	391.03%	-70.76%	4.46%	120.51%	-41.25%	25.77%	36.46%
EPS	-2.24	0.71	-3.71	-4.15	-3.14	-4.27	-4.36	-3.95
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	276.2M	297.9M	390.3M
Avg	151.6M	190.6M	260.1M
Low	78.4M	88.2M	99.2M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	7.0%	96.5%	104.7%
Avg	-41.3%	25.8%	36.5%
Low	-69.6%	-41.8%	-48.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-3.52	-2.79	-1.20
Avg	-4.27	-4.36	-3.95
Low	-5.72	-6.45	-5.80

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.